Literature DB >> 10446773

An immunohistochemical study of basal cell carcinoma and trichoepithelioma.

A W Poniecka1, J B Alexis.   

Abstract

The histologic distinction between tricheopithelioma and basal cell carcinoma may be difficult in small biopsies. Immunohistochemical stains have been used to help make this distinction; however, published studies have generally been limited to a few antibodies. To this end we performed a comprehensive immunohistochemical analysis of 20 basal cell carcinomas and 10 tricheopitheliomas from our files, in search of a consistent pattern of reactivity to distinguish the neoplasms in biopsies. The antibodies used were: low molecular weight keratin (Cam 5.2), Cytokeratin 7, (CK7), Cytokeratin 20, (CK20), Carcino-embryonic antigen (CEA), CD30 (Ki-1), bcl-2, Ham 56, HPCA-I (CD34), and Ulex Europaeus type I. In our study, bcl-2 stained all but one basal cell carcinoma in a diffuse pattern, whereas all tricheopitheliomas showed staining of the outermost epithelial layer. No other stain proved to be an independent marker for either neoplasm and no consistent immunohistochemical profile for either neoplasm emerged. Thus, we conclude that bcl-2 may be of some value in distinguishing basal cell carcinoma from tricheopithelioma, limited by the quantitative nature of the difference in staining. Histologic criteria applied to H&E-stained sections remain the cornerstone of histologic diagnosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446773     DOI: 10.1097/00000372-199908000-00004

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  14 in total

Review 1.  Skin adnexal neoplasms--part 1: an approach to tumours of the pilosebaceous unit.

Authors:  K O Alsaad; N A Obaidat; D Ghazarian
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

2.  Diagnostic utility of cytokeratin 17 immunostaining in morpheaform basal cell carcinoma and for facilitating the detection of tumor cells at the surgical margins.

Authors:  Heidi Anderson-Dockter; Todd Clark; Satori Iwamoto; Ming Lu; David Fiore; Jane K Falanga; Vincent Falanga
Journal:  Dermatol Surg       Date:  2012-06-12       Impact factor: 3.398

Review 3.  Update on Merkel Cell Carcinoma.

Authors:  Michael T Tetzlaff; Priyadharsini Nagarajan
Journal:  Head Neck Pathol       Date:  2018-03-20

4.  Blood vessel density in Basal cell carcinomas and benign trichogenic tumors as a marker for differential diagnosis in dermatopathology.

Authors:  Julia Winter; Hermann Kneitz; Eva-B Bröcker
Journal:  J Skin Cancer       Date:  2010-10-07

5.  Basal Cell Carcinoma Developing from Trichoepithelioma: Review of Three Cases.

Authors:  Anji Reddy Kallam; M Ananta Satyanarayana; Sirish Aryasomayajula; B A Rama Krishna
Journal:  J Clin Diagn Res       Date:  2016-03-01

6.  CD10 expression helps to differentiate basal cell carcinoma from trichoepithelioma.

Authors:  Mitra Heidarpour; Parvin Rajabi; Farzaneh Sajadi
Journal:  J Res Med Sci       Date:  2011-07       Impact factor: 1.852

7.  Significance of androgen receptor and CD10 expression in cutaneous basal cell carcinoma and trichoepithelioma.

Authors:  Hesna M Astarci; Gulfem A Gurbuz; Demet Sengul; Sema Hucumenoglu; Ugur Kocer; Huseyin Ustun
Journal:  Oncol Lett       Date:  2015-10-13       Impact factor: 2.967

Review 8.  Fibroepithelioma of Pinkus Revisited.

Authors:  Ellen S Haddock; Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2016-06-21

9.  The rate and pattern of bcl-2 and cytokeratin 15 expression in trichoepithelioma and nodular Basal cell carcinoma: a comparative study.

Authors:  Shahram Sabeti; Farhad Malekzad; Mehrdad Ashayer; Rohollah F Fouladi; Kambiz K Hesari; Mihan P Toutkaboni; Shima Younespour
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

Review 10.  Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.

Authors:  Leigh A Compton; George F Murphy; Christine G Lian
Journal:  Dermatopathology (Basel)       Date:  2015-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.